FRUMIL furosemide (frusemide) 40 mg and amiloride hydrochloride dihydrate 5 mg tablets

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

furosemide, Quantity: 40 mg; amiloride hydrochloride dihydrate, Quantity: 5 mg

Available from:

Sanofi-Aventis Australia Pty Ltd

INN (International Name):

amiloride hydrochloride dihydrate,furosemide (frusemide)

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate type A; maize starch; sunset yellow FCF; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc

Administration route:

Oral

Units in package:

28

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

FRUMIL is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

Product summary:

Visual Identification: Orange tablets with breakline; FRUMIL on reverse side.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2007-08-20